MAPT and Alzheimer disease: Interestingly, in nondemented control tissues, antibodies indicating gingipain to ubiquitin load and gingipain load and tau load revealed some AD pathology was present in controls preclinically (meaning no observation of clinical signs or symptoms were present in non-demented, healthy controls).